Lv52
910 积分 2024-04-25 加入
Pathological complete response after conversion therapy in unresectable hepatocellular carcinoma: a retrospective study
1个月前
已完结
Hepatic Resection versus Transarterial Lipiodol Chemoembolization as the Initial Treatment for Large, Multiple, and Resectable Hepatocellular Carcinomas: A Prospective Nonrandomized Analysis
3个月前
已完结
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience
3个月前
已完结
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma
3个月前
已完结
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
3个月前
已完结
Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy
4个月前
已关闭
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study
4个月前
已完结
Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
4个月前
已完结
Hepatocellular carcinoma
4个月前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
4个月前
已完结
皖公网安备34019202002308
